- Home
- AVA vs TVTX Comparison
AVA vs TVTX Comparison
Compare AVA & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVA | TVTX |
|---|---|---|
| Founded | 1889 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AVA | TVTX |
|---|---|---|
| Price | $42.42 | $29.52 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 15 |
| Target Price | ★ $38.00 | $37.21 |
| AVG Volume (30 Days) | 626.2K | ★ 2.9M |
| Earning Date | 02-25-2026 | 02-19-2026 |
| Dividend Yield | ★ 4.62% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.35 | N/A |
| Revenue | ★ $1,964,000,000.00 | $435,826,000.00 |
| Revenue This Year | $1.44 | $121.25 |
| Revenue Next Year | N/A | $36.79 |
| P/E Ratio | $18.04 | ★ N/A |
| Revenue Growth | 2.14 | ★ 114.22 |
| 52 Week Low | $35.50 | $12.91 |
| 52 Week High | $43.09 | $42.13 |
Technical Indicators
Market Signals| Indicator | AVA | TVTX |
|---|---|---|
| Relative Strength Index (RSI) | 74.43 | 43.84 |
| Support Level | $39.73 | $29.31 |
| Resistance Level | $41.23 | $33.14 |
| Average True Range (ATR) | 0.70 | 1.57 |
| MACD | 0.23 | 0.19 |
| Stochastic Oscillator | 100.00 | 54.60 |
Price Performance
Historical ComparisonAbout AVA Avista Corporation
Avista Corp is an electric and natural gas utility company. The company has two business segments including Avista Utilities, which provides electric distribution and transmission, and natural gas distribution services in parts of eastern Washington and northern Idaho, and also provides natural gas distribution service in parts of northeastern and southwestern Oregon. Avista Utilities has electric generating facilities in Washington, Idaho, Oregon, and Montana. AEL&P is a regulated utility providing electric services in Juneau, Alaska that is a wholly-owned subsidiary and the primary operating subsidiary of AERC.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.